Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
about
Interaction between Glucose and Lipid Metabolism: More than Diabetic DyslipidemiaFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewJTT-705: is there still future for a CETP inhibitor after torcetrapib?Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk ReductionCholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.Beneficial effects of Hibiscus rosa-sinensis L. flower aqueous extract in pregnant rats with diabetes.Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, NigeriaHypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl estersHIV and HAART-Associated DyslipidemiaLowering triglycerides to modify cardiovascular risk: will icosapent deliver?Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.Postprandial metabolic heterogeneity in men with primary dyslipidaemia.A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients.Beyond the statins: new therapeutic perspectives in cardiovascular disease prevention.Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention.PPAR Agonists and Cardiovascular Disease in Diabetes.Atherogenic Index of Plasma (AIP): A marker of cardiovascular diseaseThematic review series: patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans?Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles.CETP inhibition in cardiovascular risk management: a critical appraisal.Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients.Longitudinal Associations between Triglycerides and Metabolic Syndrome Components in a Beijing Adult Population, 2007-2012.Who needs to care about small, dense low-density lipoproteins?The effect of intensive glucose lowering on lipoprotein particle profiles and inflammatory markers in the Veterans Affairs Diabetes Trial (VADT).Ameliorative effect of black tea on nicotine induced cardiovascular pathogenesis in rat.Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development.Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia.Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma.Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro.Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance?Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (prShould we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells.Atherogenic index of plasma in non-obese women with androgenetic alopecia.Lotus leaf alleviates hyperglycemia and dyslipidemia in animal model of diabetes mellitus.Elevated cholesteryl ester transfer protein concentration is associated with an increased risk for cardiovascular disease in women, but not in men, with Type 2 diabetes: the Hoorn Study.Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state.
P2860
Q26777184-32D8D887-BAFB-47DD-B9D9-D4938BF6E173Q28220294-EEC444C2-81D6-454D-9BCE-58A3506F9A89Q28294797-1E583A48-F4C0-4C81-BAE2-82BB2ABF8CBDQ29999973-A76DDB60-AC57-4760-AA10-4FB999344D1EQ33590777-EA3B8DB6-F738-43AD-8B77-4A6CB9B7D344Q33752486-5635B89D-7E84-477C-9715-C8E97DB3C317Q33828860-2361F279-35A1-4D33-BC4B-B1C595F6CF12Q34562097-27D674C9-8B54-45A6-AB01-8B771CA48738Q34687470-2E66E6E9-0BED-4AE4-9610-1BCBFDAC09D2Q34703867-B9BD661E-BABD-4AC9-83B3-3411E072BFB4Q35020217-F12242A2-758D-4B2D-B0B1-05831C5937FAQ35230819-D1A3EE73-C681-447F-9AF0-B821992BD86CQ35592465-5DCED980-C221-4AF3-AD26-710AED7494D0Q35827366-18A0C358-B261-4C43-8064-A2463D9989C9Q35994373-3966CC68-EFC5-49CA-9BC9-E3AC8B21D114Q36198208-2FB9CE1B-DF87-41FA-8F36-F6E6DBEE63E1Q36401585-481C80E0-286A-43AA-9AAE-89E1A5E05970Q36444975-45985F6A-48E6-4D17-8E30-9CD25BD4A2AEQ36469378-E24A00C7-0627-4DF3-90BC-FAE7742DDBA8Q36473656-070F1E22-1F62-422B-8A87-5F6AA3D23998Q36675450-F078BFE0-D8AA-40E6-8F50-357E71AD618AQ36705260-E76E966B-4C3B-4D93-BEF8-5F5C3334E05AQ36847283-89E0FC32-DD88-469C-BDCE-514CA4ECE9C5Q36951647-64D80338-917B-450D-875A-E7A951EC5808Q36970062-4B3F5092-461B-4653-99E0-F5A0A6F81E39Q36970686-F9FD181B-67A1-4D91-B265-B51D577A6490Q37022679-2FCAA207-EBFF-46F9-AEB9-A7A77A923644Q37089598-8F432B3A-0025-455C-8331-0A1EC65A937EQ37119309-C7430BA4-2E9B-4598-9C8D-038B6EF54F67Q37268436-7916CF4D-D2BB-42DA-BBF4-FE8D062FF654Q37299858-CF5B01B7-40EA-4186-8C72-5CD43E16BB29Q37382142-6FA07FD0-5B39-4EFD-A98E-D2C1F837BF50Q37394899-CA93306B-BFD2-4F1C-ACF5-E76CAD6D61BCQ37660996-A22BC54F-D0E4-424C-BDA8-9A33C85BC22BQ37787320-1AB00F6A-6BA8-4ECB-9FDA-64FEEE35F284Q40397960-26C6E4D1-829C-40D7-AEA5-DB8F5D559951Q41652194-FA0C0C23-C4E8-4BA0-A6DE-5F288F886094Q41899851-BAA2BE21-8710-4C67-80C7-AAAE8632C33AQ43576051-042D7748-869C-4A1E-84D9-C8043C15340BQ44168295-BD4061CD-DBA9-42B7-BAB9-534E640A3C61
P2860
Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Atherogenic role of elevated C ...... the degree of triglyceridemia.
@ast
Atherogenic role of elevated C ...... the degree of triglyceridemia.
@en
type
label
Atherogenic role of elevated C ...... the degree of triglyceridemia.
@ast
Atherogenic role of elevated C ...... the degree of triglyceridemia.
@en
prefLabel
Atherogenic role of elevated C ...... the degree of triglyceridemia.
@ast
Atherogenic role of elevated C ...... the degree of triglyceridemia.
@en
P2093
P356
P1476
Atherogenic role of elevated C ...... the degree of triglyceridemia.
@en
P2093
P304
P356
10.1161/01.ATV.21.2.282
P407
P577
2001-02-01T00:00:00Z